Theorem Clinical Research has entered a strategic alliance with BioTelemetry, Inc. and its clinical research division Cardiocore, a global cardiac core lab. Financial terms of the pact were not disclosed.
Discussing the alliance, John Potthoff, Theorem president and chief executive officer, remarked, “Theorem’s business strategy is to offer our clients the very best in every service area. BioTelemetry reinforces that strategy with a team of industry-leading scientists, a set of advanced technologies and a broad base of cardiac testing modalities. Theorem clients will benefit from BioTelemetry’s expert consulting services and deep experience across all major therapeutic areas.”
BioTelemetry’s chief executive officer, Joseph Capper, said, “Theorem’s experience in complex protocols aligns perfectly with our specialized cardiovascular testing services. The partnership complements BioTelemetry’s unique position that spans from clinical research through post-market surveillance and into clinical practice. Both companies support trials in all clinical phases of pharmaceutical and biotech development and will collaborate globally within this alliance.”